Recall
FDAHealthJanuary 30, 2025

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories — Potassium Chloride Extended-Release Tablets, USP, 10 mEq (750 mg), 100 Tablets per carton (10 x 10 unit dose blisters), Rx

⚠️ Failed Dissolution Specifications.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
January 30, 2025

Nationwide in the USA

What's affected?

Product
Potassium Chloride Extended-Release Tablets, USP, 10 mEq (750 mg), 100 Tablets per carton (10 x 10 unit dose blisters), Rx Only, Distributed by: Aurobindo Pharma USA< INC., 279 Princeton-Hightstown Road, East Windsor, NJ 08520. Made in India. Distributed by: MAJOR PHARMACEUTICALS, Livonia, MI 48152. NDC: 0904-7216-61
Lot code
T05224

Additional details

Lot# T05224; Exp. 02/2026

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 6997 cartons.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.